Roberts Zachary
SEC CIK 1851044 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ALLO | Allogene Therapeutics, Inc. | EVP of R, D | 581.2K | — | $184.6K | 9 | 2023-01-20 | 2026-02-02 |
Most active insiders at ALLO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Chang David D | Pres, CEO, Dir | — | $289.5K |
| 2 | Roberts Zachary | EVP of R, D | — | $104.2K |
| 3 | Douglas Earl Martin | SVP, GC | — | $103.3K |
| 4 | Parker Geoffrey M. | CFO | — | $88.5K |
| 5 | Beneski Benjamin Machinas | SVP, Chief Technical Off | — | $51.7K |
| 6 | Yoshiyama Annie | SVP, Fin | — | $29.3K |
| 7 | Kazam Joshua A | Dir | — | — |
Transactions 9
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-04 | 2026-02-02 | ALLO | Allogene Therapeutics, Inc. | Roberts Zachary | EVP of R, D | S - Sale | $1.77 | -35.7K | 581.2K | -6% | -$63.2K |
| 2026-01-23 | 2026-01-21 | ALLO | Allogene Therapeutics, Inc. | Roberts Zachary | EVP of R, D | S - Sale | $1.56 | -26.3K | 616.9K | -4% | -$41.0K | |
| 2025-02-05 | 2025-02-03 | ALLO | Allogene Therapeutics, Inc. | Roberts Zachary | EVP of R, D | S - Sale | $1.70 | -18.8K | 643.1K | -3% | -$32.0K | |
| D | 2025-01-28 | 2025-01-24 | ALLO | Allogene Therapeutics, Inc. | Roberts Zachary | EVP of R, D | A - Grant | $0.00 | +173.9K | 662.0K | +36% | $0 |
| 2025-01-23 | 2025-01-21 | ALLO | Allogene Therapeutics, Inc. | Roberts Zachary | EVP of R, D | S - Sale | $1.78 | -27.2K | 488.1K | -5% | -$48.4K | |
| D | 2024-01-31 | 2024-01-25 | ALLO | Allogene Therapeutics, Inc. | Roberts Zachary | EVP of R, D | A - Grant | $0.00 | +140.0K | 515.3K | +37% | $0 |
| 2024-01-24 | 2024-01-22 | ALLO | Allogene Therapeutics, Inc. | Roberts Zachary | EVP of R, D | F - Tax | $3.17 | -24.7K | 375.3K | -6% | -$78.3K | |
| 2023-03-24 | 2023-03-22 | ALLO | Allogene Therapeutics, Inc. | Roberts Zachary | EVP of R, D | A - Grant | $0.00 | +148.0K | 399.9K | +59% | $0 | |
| D | 2023-01-24 | 2023-01-20 | ALLO | Allogene Therapeutics, Inc. | Roberts Zachary | EVP of R, D | A - Grant | $0.00 | +251.9K | 251.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations